Wednesday 3 April 2019

No US commercial laboratories fully meet guidance for noninvasive prenatal screening

An analysis of the reports and materials provided by commercial laboratories offering noninvasive prenatal screening (NIPS) for genetic disorders finds that none of them fully meet the recommendations published by the American College of Medical Genetics and Genomics (ACMG). The report from a team of specialists in medical genetics is being published in the journal Genetics in Medicine.

* This article was originally published here